tiprankstipranks
Advertisement
Advertisement
NewcelX announces research agreement with Eledon Pharmaceuticals
PremiumThe FlyNewcelX announces research agreement with Eledon Pharmaceuticals
21d ago
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
2M ago
Eledon Pharmaceuticals presents long-term Phase 1b data for tegoprubart
Premium
The Fly
Eledon Pharmaceuticals presents long-term Phase 1b data for tegoprubart
2M ago
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
PremiumRatingsEledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
4M ago
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
Premium
The Fly
Eledon Pharmaceuticals reports Q3 EPS (21c), consensus (25c)
5M ago
Eledon Pharmaceuticals options imply 14.1% move in share price post-earnings
Premium
The Fly
Eledon Pharmaceuticals options imply 14.1% move in share price post-earnings
5M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Friday’s Biggest Stock Market Stories!
5M ago
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
Premium
Ratings
Eledon Pharmaceuticals’ Tegoprubart: Promising Safety Profile and Market Potential Despite eGFR Setback
5M ago
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
Premium
Market News
Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100